Carna Biosciences, Inc.

Carna Biosciences, Inc.verified

CBIXF

Price:

$10.75

Market Cap:

$7.09B

Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases to use in the study of kinase-molecule interactions. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection and interaction, live-cell kinase assay, ClariCELL kinase cell-based assay, crystallization, weak affinity chromatography, and tyrosine kinase cell-based assay services, as well as custom production of ultra-pure proteins for crystallography. It also focuses on dev...[Read more]

Industry

Biotechnology

IPO Date

2019-07-08

Stock Exchange

OTC

Ticker

CBIXF

The PE Ratio as of December 2025 (TTM) for Carna Biosciences, Inc. (CBIXF) is -71.67

According to Carna Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -71.67. This represents a change of 2.75% compared to the average of -2.52 of the last 4 quarters.

Carna Biosciences, Inc. (CBIXF) Historical PE Ratio (quarterly & annually)

How has CBIXF PE Ratio performed in the past?

The mean historical PE Ratio of Carna Biosciences, Inc. over the last ten years is -6.40. The current -71.67 PE Ratio has changed 111.92% with respect to the historical average. Over the past ten years (40 quarters), CBIXF's PE Ratio was at its highest in in the December 2023 quarter at 28.89. The PE Ratio was at its lowest in in the March 2016 quarter at -681.34.

Quarterly (TTM)
Annual

Average

-6.40

Median

-7.40

Minimum

-67.15

Maximum

51.74

Carna Biosciences, Inc. (CBIXF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Carna Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 95.10%

Maximum Annual PE Ratio = 51.74

Minimum Annual Increase = -801.16%

Minimum Annual PE Ratio = -67.15

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2.47-67.58%
2023-7.6144.97%
2022-5.25-79.96%
2021-26.1895.10%
2020-13.42-148.06%
201927.91-487.75%
2018-7.20-49.88%
2017-14.36-78.61%
2016-67.15-229.79%
201551.74-801.16%

Carna Biosciences, Inc. (CBIXF) Average PE Ratio

How has CBIXF PE Ratio performed in the past?

The current PE Ratio of Carna Biosciences, Inc. (CBIXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-5.11

5-year avg

-10.98

10-year avg

-6.40

Carna Biosciences, Inc. (CBIXF) PE Ratio vs. Peers

How is CBIXF’s PE Ratio compared to its peers?

Carna Biosciences, Inc.’s PE Ratio is less than Adocia S.A. (-11.26), less than Recce Pharmaceuticals Ltd (-6.63), less than AnGes, Inc. (-0.92), less than Broncus Holding Corporation (-10.13), less than Prescient Therapeutics Limited (0), less than NanoRepro AG (-9.28), less than Faron Pharmaceuticals Oy (-10.22), less than Ascentage Pharma Group International (-62.93), less than Eupraxia Pharmaceuticals Inc. (-6.99), less than EKF Diagnostics Holdings plc (16.10),

Build a custom stock screener for Carna Biosciences, Inc. (CBIXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carna Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carna Biosciences, Inc. (CBIXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carna Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Carna Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Carna Biosciences, Inc. (CBIXF)?

What is the highest PE Ratio for Carna Biosciences, Inc. (CBIXF)?

What is the 3-year average PE Ratio for Carna Biosciences, Inc. (CBIXF)?

What is the 5-year average PE Ratio for Carna Biosciences, Inc. (CBIXF)?

How does the current PE Ratio for Carna Biosciences, Inc. (CBIXF) compare to its historical average?